Don’t Miss: INVO Bioscience, Inc. (INVO) Makes an Approx 33% Move in Under 24 Hours

Immediately start your research on INVO Bioscience, Inc. (INVO).

Today’s Watchlist: Immediate Put INVO Bioscience, Inc. (INVO) #1 on Your Watchlist! Don’t Miss Out on This One! Take 2 Minutes Now to Connect with Us on all of Our No-Cost Platforms! (See instructions below) July 30, 2024 Dear Reader, Immediately start your research on INVO Bioscience, Inc. (INVO). INVO Bioscience, Inc. (INVO) made an approximate 33% move overnight, reaching $1.15 in the pre-market,  surpassing all key moving averages according to Barchart, including: Period Moving Average 5-Day .7891 20-Day .7852 50-Day .8408 100-Day .9431 200-Day 1.0834 Year-to-Date .9749 Analysts often overlook these under-the-radar Micro-caps and Small-caps, which could evolve into tomorrow’s industry leaders. INVO Bioscience, Inc. (INVO) must be on your watchlist early today or you could miss it. At the same time, I’m urging you to connect with us on all of our no-cost platforms so you can receive our reports up to 10X faster than email alone.  If you haven't already, please take a moment to set up these platforms now:  SMS: To make sure you’re signed up for our no-cost SMS Alerts, which are up to 10X faster than email, click here. Telegram Channel: Click now to join our no-cost Telegram Channel for real-time updates. WhatsApp: Or if you prefer WhatsApp, click here to join our real-time Market Chatter. All three of these should take less than 3 minutes to connect but give you a massive advantage in the market.  Make no mistake. INVO Bioscience, Inc. (INVO) needs to be on your watchlist today. MarketCrux (MarketCrux . com) is owned by Headline Media LLC, a limited liability company. Disclosure: I am not a lice.nsed finan.cial adviser. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. MarketCrux full disclosure is to be read and fully understood before using MarketCrux website, or joining MarketCrux's email or text list. By viewing MarketCrux website and/or reading MarketCrux email or text newsletter you are agreeing to MarketCrux full disclosure which can be read at marketcrux.com/disclaimer  We have not been compensated for today's profile on (INVO). We own zero shares of (INVO).

Headline Media | 7901 4th Street N Suite 300 | St. Petersburg, FL 33702 US Unsubscribe | Update Profile | Constant Contact Data Notice